Baseline patient characteristics
. | Group A1, n = 88 . | Group A2, n = 92 . | Group B, n = 78 . | P* . |
---|---|---|---|---|
Female sex, no. (%) | 43 (46.7) | 42 (47.7) | 37 (47.4) | .991 |
Mean age, y (± SD) | 57.1 (± 14.1) | 61.1 (± 11.5) | 55.3 (± 14.9) | .017‡ |
Type of DVT, no. (%) | ||||
Idiopathic | 66 (75.0) | 72 (78.3) | 28 (35.9) | .001 |
Provoked | 22 (25.0) | 20 (21.7) | 50 (64.1) | .001 |
Total duration of follow-up, y† | 184.2 | 191.0 | 157.9 | |
Mean follow-up, y† | 2.1 (± 0.71) | 2.1 (± 0.68) | 2.0 (± 0.71) |
. | Group A1, n = 88 . | Group A2, n = 92 . | Group B, n = 78 . | P* . |
---|---|---|---|---|
Female sex, no. (%) | 43 (46.7) | 42 (47.7) | 37 (47.4) | .991 |
Mean age, y (± SD) | 57.1 (± 14.1) | 61.1 (± 11.5) | 55.3 (± 14.9) | .017‡ |
Type of DVT, no. (%) | ||||
Idiopathic | 66 (75.0) | 72 (78.3) | 28 (35.9) | .001 |
Provoked | 22 (25.0) | 20 (21.7) | 50 (64.1) | .001 |
Total duration of follow-up, y† | 184.2 | 191.0 | 157.9 | |
Mean follow-up, y† | 2.1 (± 0.71) | 2.1 (± 0.68) | 2.0 (± 0.71) |